This Article Full Text Full Text (PDF) All Versions of this Article: 92/6/2017    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pittas, A. G. Articles by Dawson-Hughes, B. Search for Related Content PubMed PubMed Citation Articles by Pittas, A. G. Articles by Dawson-Hughes, B. Related Collections Calcium and Bone Metabolism Diabetes and Insulin Metabolism

The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis

Divisions of Endocrinology, Diabetes and Metabolism (A.G.P., B.D.-H.), and Clinical Research (J.L.), Tufts-New England Medical Center, Boston, Massachusetts 02111; Harvard School of Public Health and Channing Laboratory (F.B.H.), Boston, Massachusetts 02115; and Bone Metabolism Laboratory (B.D.-H.), Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts 02111

Address all correspondence and requests for reprints to: Anastassios G. Pittas, M.D., M.Sc., Division of Endocrinology, Diabetes and Metabolism, Tufts-New England Medical Center, 750 Washington Street, #268, Boston, Massachusetts 02111. E-mail: apittas{at}tufts-nemc.org.

Context: Altered vitamin D and calcium homeostasis may play a role in the development of type 2 diabetes mellitus (type 2 DM).

Evidence Acquisition and Analyses: MEDLINE review was conducted through January 2007 for observational studies and clinical trials in adults with outcomes related to glucose homeostasis. When data were available to combine, meta-analyses were performed, and summary odds ratios (OR) are presented.

Evidence Synthesis: Observational studies show a relatively consistent association between low vitamin D status, calcium or dairy intake, and prevalent type 2 DM or metabolic syndrome [OR (95% confidence interval): type 2 DM prevalence, 0.36 (0.16–0.80) among nonblacks for highest vs. lowest 25-hydroxyvitamin D; metabolic syndrome prevalence, 0.71 (0.57–0.89) for highest vs. lowest dairy intake]. There are also inverse associations with incident type 2 DM or metabolic syndrome [OR (95% confidence interval): type 2 DM incidence, 0.82 (0.72–0.93) for highest vs. lowest combined vitamin D and calcium intake; 0.86 (0.79–0.93) for highest vs. lowest dairy intake]. Evidence from trials with vitamin D and/or calcium supplementation suggests that combined vitamin D and calcium supplementation may have a role in the prevention of type 2 DM only in populations at high risk (i.e. glucose intolerance). The available evidence is limited because most observational studies are cross-sectional and did not adjust for important confounders, whereas intervention studies were short in duration, included few subjects, used a variety of formulations of vitamin D and calcium, or did post hoc analyses.

Conclusions: Vitamin D and calcium insufficiency may negatively influence glycemia, whereas combined supplementation with both nutrients may be beneficial in optimizing glucose metabolism.

This article has been cited by other articles:

				J. P Reis, D. von Muhlen, and E. R Miller III Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur. J. Endocrinol., July 1, 2008; 159(1): 41 - 48. [Abstract] [Full Text] [PDF]

				E. Giovannucci, Y. Liu, B. W. Hollis, and E. B. Rimm 25-Hydroxyvitamin D and Risk of Myocardial Infarction in Men: A Prospective Study Arch Intern Med, June 9, 2008; 168(11): 1174 - 1180. [Abstract] [Full Text] [PDF]

				M. A Beydoun, T. L Gary, B. H Caballero, R. S Lawrence, L. J Cheskin, and Y. Wang Ethnic differences in dairy and related nutrient consumption among US adults and their association with obesity, central obesity, and the metabolic syndrome Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1914 - 1925. [Abstract] [Full Text] [PDF]

				Y. Talmor, E. Golan, S. Benchetrit, J. Bernheim, O. Klein, J. Green, and G. Rashid Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1059 - F1064. [Abstract] [Full Text] [PDF]

				P. Lee and R. Chen Vitamin D as an Analgesic for Patients With Type 2 Diabetes and Neuropathic Pain Arch Intern Med, April 14, 2008; 168(7): 771 - 772. [Full Text] [PDF]

				J. C. McCann and B. N. Ames Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J, April 1, 2008; 22(4): 982 - 1001. [Abstract] [Full Text] [PDF]

				I. H. de Boer, L. F. Tinker, S. Connelly, J. D. Curb, B. V. Howard, B. Kestenbaum, J. C. Larson, J. E. Manson, K. L. Margolis, D. S. Siscovick, et al. Calcium Plus Vitamin D Supplementation and the Risk of Incident Diabetes in the Women's Health Initiative Diabetes Care, April 1, 2008; 31(4): 701 - 707. [Abstract] [Full Text] [PDF]

				A. H. Lichtenstein, H. Rasmussen, W. W. Yu, S. R. Epstein, and R. M. Russell Modified MyPyramid for Older Adults J. Nutr., January 1, 2008; 138(1): 5 - 11. [Abstract] [Full Text] [PDF]

				W. W. Liang Seasonal Changes in Preprandial Glucose, A1C, and Blood Pressure in Diabetic Patients: Response to Honeyman et al. Diabetes Care, November 1, 2007; 30(11): e119 - e119. [Full Text] [PDF]